Molecular factors influencing drug transfer across the blood-brain barrier

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 12, 1997, Pages 1211-1216

  Gratton, Julie A ^a   Abraham, Michael H ^b   Bradbury, Michael W ^a   Chadha, Harpreet S ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OCTANOL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PENETRATION; FEMALE; HYDROGEN BOND; NONHUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; RAT;

EID: 0031464488     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06072.x     Document Type: Article

References (38)

1. Abraham, M. H. (1993) Scales of solute hydrogen-bonding: their construction application to physicochemical and biochemical processes. Chem. Soc. Rev. 22: 73-83
2. Abraham, M. H., Chadha, H. S. (1996) Applications of a solvation equation to drug transport properties. In: Pliska, V., Testa, B., van de Waterbeemd, H. (eds) Lipophilicity in Drug Action and Toxicity. VCH, Weinheim, Germany, pp 311-337
3. Abraham, M. H., McGowan, J. C. (1987) The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography. Chromatographia 23: 243-246
4. Abraham, M. H., Weathersby, P. K. (1994) Hydrogen bonding 30. The solubility of gases and vapors in biological liquids and tissues. J. Pharm. Sci. 83: 1450-1455
5. Abraham, M. H., Chadha, H. S., Mitchell, R. C. (1994a) Hydrogen bonding. Part 33. The factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci. 83: 1257-1268
6. Abraham, M. H., Chadha, H. S., Whiting, G. S., Mitchell, R. C. (1994b) Hydrogen bonding Part 32. An analysis of water-octanol and water-alkane partitioning and the (logP parameter of Seiler. J. Pharm. Sci. 83: 1085-1100
7. Abraham, M. H., Chadha, H. S., Mitchell, R. C. (1995) The factors that influence the skin permeation of solutes. J. Pharm. Pharmacol. 47: 8-16
8. 1 antagonist, astemizole. Arzneim. Forsch. 33: 381-388
9. Bradbury, M. W. B. (1979) The Concept of a Blood-Brain Barrier, Wiley, New York
10. Brightman, M. W., Reese, T. S. (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40: 648-677
11. Chikhale, E. G., Ng, K. Y., Burton, P. S., Borchardt, R. T. (1994) Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res. 11: 412-419
12. Chikhale, E. G., Burton, P. S., Borchardt, R. T. (1995) The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J. Pharmacol. Exp. Ther. 273: 298-303
13. Davson, H., Danielli, J. F. (1943) The Permeability of Natural Membranes, Cambridge University Press, UK
14. Deane, R., Bradbury, M. W. B. (1990) Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat. J. Neurochem. 54: 905-914
15. Dearden, J. C. (1990) Molecular structure and drug transport. In: Hansch, C. (ed.) Comprehensive Medicinal Chemistry. Vol. 64, Pergamon Press, Oxford, pp 375-411
16. Fenstermacher, J. D., Rapoport, S. I. (1984) Blood-brain barrier. In: Renkin, E. M., Michell, C. C. (eds) Handbook of Physiology, The Cerebrovascular System, Vol. IV. Part 2, American Physiological Society, Bethesda, Maryland, pp 969-1000
17. Ghersiegea, J. F., Leninger-Muller, B., Suleman, G. (1994) Localization of drug metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J. Neurochem. 62: 1089-1096
18. Gratton, J. A., Lightman, S. L., Bradbury, M. W. (1993) Transport into retina measured by short vascular perfusion in the rat. J. Physiol. 470: 651-663
19. Gupta, S. P. (1989) QSAR studies of drugs acting on the central nervous system. Chem. Rev. 89: 1765-1800
20. Hansch, C., Steward, A. R., Anderson, S. M., Bentley, D. L. (1968) The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics J. Med. Chem. 11: 1-11
21. Hansch, C., Bjorkroth, J. P., Leo, A. (1987) Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 76: 663-687
22. Heykants, J., Michielis, H., Knaeps, A., Burgmans, J. (1974) (R68553), a novel type of antidiarrheal agent. Arzneim. Forsch. 24: 1649-1653
23. Krogh, A. (1946) The active and passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally. Proc. R. Soc. Biol. 133: 140-200
24. 1 antagonist, astemizole. Mol. Pharmacol. 26: 294-300
25. Levin, V. A. (1980) Relationship of octanol water partition coefficient and molecular weight to rat brain permeability. J. Med. Chem. 23: 682-684
26. Mayer, S. E., Maickel, R. P., Brodie, B. B. (1959) Kinetics of penetration of drugs and other foreign compounds into cerebrospinal fluid and brain. J. Pharmacol. 127: 205-211
27. Ohno, K., Pettigrew, K. D., Rapoport, S. I. (1978) Lower limits of cerebrovascular permeability to non-electrolytes in the conscious rat. Am. J. Phys. 253: H299-H307
28. Pardridge, W. M. (1983) Brain metabolism: a perspective from the blood-brain barrier. Physiol. Rev. 63: 1481-1535
29. Pardridge, W. M., Triguero, D., Yang, J., Cancilla, P. A. (1990) Comparison of in-vitro and in-vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Ther. 253: 884-891
30. Rapoport, S. I., Levitan, H. (1974) Neurotoxicity of X-ray contrast media: relation to lipid solubility and blood brain barrier permeability. Am. J. Roentgenol. 122: 186-193
31. Reese, T. S., Karnovsky, M. J. (1967) Fine structural localization of the blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34: 207-217
32. Renkin, E. M. (1959) Transport of potassium-42 from blood to tissue in isolated skeletal muscles. Am. J. Phys. 197: 1205-1210
33. Seelig, A., Gottschlich, R., Devant, R. M. (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc. Natl Acad. Sci. USA 91: 68-72
34. Seiler, P. (1974) Interconversion of lipophilicities from hydrocarbon/ water systems into the octanol/water system. Eur. J. Med. Chem. 9: 473-479
35. Smith, Q. R. (1989) Quantitation of blood-brain barrier permeability. In: Neuwelt, E. A. (ed.) Implications of the Blood-Brain Barrier and its Manipulation. Vol. 6, Plenum, New York, pp 85-113
36. Takasato, Y., Rapoport, S. I., Smith, Q. R. (1984) An in situ perfusion technique to study cerebrovascular permeability in the rat. Am. J. Phys. 247: H484-H493
37. van de Waterbeemd, H., Boekel, C. C. A. A., De Sevaux, R. L. F. M., Jansen, A. C. A., Gerritsma, K. W. (1981) Transport in QSAR IV. The interfacial drug transfer model. Relationships between partition coefficients and rate constants in drug partitioning. Pharm. Weekbl. [Sci.] 3: 224-236
38. 2 receptor histamine antagonists. J. Med. Chem. 31: 656-671